FLC Capital Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,750
Closed -$237K 188
2024
Q4
$237K Hold
2,750
0.05% 157
2024
Q3
$327K Hold
2,750
0.08% 129
2024
Q2
$393K Hold
2,750
0.1% 110
2024
Q1
$353K Hold
2,750
0.09% 114
2023
Q4
$284K Hold
2,750
0.08% 124
2023
Q3
$250K Hold
2,750
0.08% 126
2023
Q2
$223K Hold
2,750
0.07% 138
2023
Q1
$219K Buy
+2,750
New +$219K 0.07% 148